Skip to main content
. 2018 Feb 27;71(8):860–871. doi: 10.1016/j.jacc.2017.12.035

Table 1.

Baseline Clinical Characteristics (N = 116)

Age, yrs 70 ± 10
Male 63 (54)
Trileaflet 83 (72)
Bicuspid 33 (28)
BSA, m2 1.90 ± 0.22
Comorbidities
 Hypertension 87 (75)
 SBP, mm Hg 133 ± 17
 DBP, mm Hg 76 ± 10
 Diabetes 23 (20)
 Coronary artery disease 34 (29)
 Atrial fibrillation 16 (14)
Risk scores
 STS, % 1.3 (1.0–2.1)
 EuroSCORE II, % 1.4 (1.0–2.4)
Drug history
 ACE inhibitor/ARB 51 (44)
 Beta-blocker 43 (37)
 Statin 74 (64)
 Aspirin 51 (44)
Blood
 Creatinine, μmol/l 85 ± 26
 eGFR, ml/min/1.73 m2 77 ± 21
 Hematocrit, % 40.4 ± 4.5
Histology
 Collagen volume fraction, % 7.7 (4.2–12.7)

Values are mean ± SD, n (%), or median (interquartile range).

ACE = angiotensin-converting-enzyme; ARB = angiotensin receptor blocker; BSA = body surface area; DBP = diastolic blood pressure; eGFR = estimated glomerular filtration rate; EuroSCORE II = European System for Cardiac Operative Risk Evaluation II score; IQR = interquartile range; LVH = left ventricular hypertrophy; NYHA = New York Heart Association; SBP = systolic blood pressure; STS = The Society of Thoracic Surgeons risk model score.

One patient had unicuspid aortic stenosis (female).

n = 91.